Suppr超能文献

中国山东四期乳腺癌患者恐惧进展与症状负担、疾病因素及社会/家庭因素的关系。

Relationship between fear of progression and symptom burden, disease factors and social/family factors in patients with stage-IV breast cancer in Shandong, China.

机构信息

Department of Breast Cancer Internal Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.

出版信息

Cancer Med. 2024 Feb;13(4):e6749. doi: 10.1002/cam4.6749.

Abstract

OBJECTIVE

To assess fear of progression (FoP)'s relationship with symptom burden and disease and social/family factors, as well as, determine the status of FoP in women with stage-IV breast cancer in Shandong, China.

METHODS

Two hundred and sixteen women were recruited from the department of breast cancer internal medicine, Shandong Cancer Hospital and Institute. Data for this observational study were collected between October 2020 and January 2021 using the MD Anderson Symptom Inventory, the Fear of Progression Questionnaire-Short Form (FoP-Q-SF) and a participant information scale. SPSS 23.0 was used for statistical analysis.

RESULTS

After excluding invalid responses, the data of 200 participants were analysed. The average total FoP-Q-SF score was 29.39 ± 9.39 (95% confidence interval, 21.81-27.64). The FoP level among the participants was relatively low. For disease and social/family factors, FoP statistically significantly differed by satisfaction with family emotional support and the Eastern Cooperative Oncology Group (ECOG) score. The ECOG score was positively correlated with FoP. Furthermore, symptom burden was positively correlated with FoP.

CONCLUSIONS

Among patients with stage-IV breast cancer, satisfaction with family emotional support, ECOG score and symptom burden play key roles in FoP. Interventions, including providing appropriate emotional support from family, improving physical fitness and relieving symptom burden, must be considered in future studies, which may improve patients' overall physical and mental status and provide a supportive therapeutic environment.

摘要

目的

评估进展恐惧(FoP)与症状负担和疾病及社会/家庭因素的关系,并确定中国山东 IV 期乳腺癌女性的 FoP 现状。

方法

从山东省肿瘤医院乳腺内科招募了 216 名女性。本观察性研究的数据于 2020 年 10 月至 2021 年 1 月期间通过 MD 安德森症状量表、进展恐惧问卷-短表(FoP-Q-SF)和参与者信息量表收集。使用 SPSS 23.0 进行统计分析。

结果

剔除无效回复后,分析了 200 名参与者的数据。FoP-Q-SF 总分的平均得分为 29.39±9.39(95%置信区间,21.81-27.64)。参与者的 FoP 水平相对较低。在疾病和社会/家庭因素方面,FoP 在家庭情感支持满意度和东部合作肿瘤组(ECOG)评分方面存在统计学差异。ECOG 评分与 FoP 呈正相关。此外,症状负担与 FoP 呈正相关。

结论

在 IV 期乳腺癌患者中,家庭情感支持满意度、ECOG 评分和症状负担在 FoP 中起着关键作用。在未来的研究中,必须考虑包括提供适当的家庭情感支持、改善身体健康和减轻症状负担等干预措施,这可能会改善患者的整体身心状况,并提供支持性的治疗环境。

相似文献

3
The effect of fear of progression on quality of life among breast cancer patients: the mediating role of social support.
Health Qual Life Outcomes. 2021 Jul 10;19(1):178. doi: 10.1186/s12955-021-01816-7.
7
Mediation Effects of Coping Styles on Fear of Progression and Reproductive Concerns in Breast Cancer Patients of Reproductive Age.
Asian Nurs Res (Korean Soc Nurs Sci). 2023 Dec;17(5):245-252. doi: 10.1016/j.anr.2023.11.002. Epub 2023 Nov 7.
8
Self-efficacy and fear of cancer progression during the year following diagnosis of breast cancer.
Psychooncology. 2013 Jan;22(1):39-45. doi: 10.1002/pon.2054. Epub 2011 Sep 4.
9
Psychometric properties of the Fear of Progression Questionnaire for parents of children with cancer (FoP-Q-SF/PR).
J Psychosom Res. 2018 Apr;107:7-13. doi: 10.1016/j.jpsychores.2018.01.008. Epub 2018 Jan 17.
10
Fear of disease progression in adult ambulatory patients with brain cancer: prevalence and clinical correlates.
Support Care Cancer. 2019 Sep;27(9):3521-3529. doi: 10.1007/s00520-019-04665-9. Epub 2019 Jan 25.

本文引用的文献

1
Death anxiety predicts fear of Cancer recurrence and progression in ovarian Cancer patients over and above other cognitive factors.
J Behav Med. 2023 Dec;46(6):1023-1031. doi: 10.1007/s10865-023-00422-w. Epub 2023 Jun 12.
3
Effects of psychosocial interventions for caregivers of breast cancer patients: A systematic review and meta-analysis.
Heliyon. 2023 Feb 14;9(2):e13715. doi: 10.1016/j.heliyon.2023.e13715. eCollection 2023 Feb.
4
Are fear of cancer recurrence and fear of progression equivalent constructs?
Psychooncology. 2022 Aug;31(8):1381-1389. doi: 10.1002/pon.5944. Epub 2022 May 1.
6
and its ginsenosides: potential candidates for the prevention and treatment of chemotherapy-induced side effects.
J Ginseng Res. 2021 Nov;45(6):617-630. doi: 10.1016/j.jgr.2021.03.001. Epub 2021 Mar 5.
7
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
9
The influence of coping types on post-traumatic growth in patients with primary breast cancer.
Jpn J Clin Oncol. 2021 Jan 1;51(1):85-91. doi: 10.1093/jjco/hyaa159.
10
Fear of disease progression and psychological stress in cancer patients under the outbreak of COVID-19.
Psychooncology. 2020 Sep;29(9):1395-1398. doi: 10.1002/pon.5451. Epub 2020 Jul 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验